Financial Performance Overview

Jeena Sikho Lifecare Limited reported financial results for Q1 FY27 (quarter ended June 30, 2026) with revenue from operations of ₹224.4 crore, representing 29% growth compared to ₹174.3 crore in Q1 FY26.

Revenue Breakdown by Business Channel

The company provided detailed revenue and volume metrics across different business channels:

| Business Channel | Revenue (₹ crore) | YoY Growth | Volume Metric | Volume Growth |

| IPD – Panchakarma (private-pay) | 84.8 | +26% | 11,500 admissions | +33% |

| OPD – Medicine (at-centre) | 78.9 | +18% | 1.51 lakh footfall | +22% |

| E-commerce – Medicine (COD) | 40.5 | +1.9x | 2.82 lakh orders | +3.9x |

| Day-care – Panchakarma | 10.0 | +46% | 19,419 sessions | +31% |

| IPD - Panchakarma (Govt Panel) | 5.2 | -67% | 975 patients | -52% |

| Consultation (OPD & tele) | 4.5 | +10% | 69,119 consults | +65% |

| Diagnostics | 1.3 | New | - | - |

| Total revenue* | 224.4 | +29% | - | - |

*Total includes net loyalty/other adjustments

Healthcare Services Performance

Healthcare services revenue increased 13% YoY to ₹106.0 crore. The services growth was comprised of:

  • Private-pay IPD revenue: ₹84.8 crore (+26% YoY)
  • Government Panel revenue: ₹5.2 crore (-67% YoY, down from ₹15.5 crore in Q1 FY26)

Business Mix Shift Analysis

The company highlighted a significant shift in business mix:

  • Government Panel share of total revenue decreased from 8.9% to 2.3%
  • Government Panel share of total services revenue decreased from 16.5% to 4.9%
  • Private-pay admissions grew from 8,616 to 11,500 (+33%)
  • On a blended basis (private + Government Panel), total IPD volume grew 16.9% and total IPD revenue grew 8.8%

Strategic Focus and Operating Metrics

The company is focusing on optimizing centre economics as the network scales, with emphasis on:

  • ARPOB (Average Revenue Per Occupied Bed)
  • Average length of stay
  • Patient mix optimization
  • Quality of patient outcomes
  • Sustainable profitable growth

Management Commentary

Acharya Manish Grover, Managing Director and Chairman, commented: "Q1 FY27 reflects continued scale-up across our integrated healthcare and medicines platform. Private-pay IPD admissions increased 33%, while our e-commerce medicine channel expanded sharply as we continued to build access across physical and digital formats. Healthcare services growth was moderated by our lower government-panel mix, consistent with our strategy of remaining predominantly private-pay. As the network expands, our focus remains on disciplined centre economics, quality of patient outcomes and sustainable profitable growth."

Additional Information

The information has been uploaded to the company website at www.jeenasikho.com. The press release was issued from Zirakpur, Punjab on August 20, 2026.